Literature DB >> 7644237

Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance.

Barbara S Shapiro1, David F Dinges, Emily Carota Orne, Nancy Bauer, Linnette B Reilly, Wayne G Whitehouse, Kwaku Ohene-Frempong, Martin T Orne.   

Abstract

Some children and adolescents with sickle cell disease experience frequent painful episodes. To gain information about the natural history of the pain and its impact on sleep and school attendance, we developed a home-based diary system. Eighteen children and adolescents completed 4756 diary days, with an average compliance of 75%. Pain was reported on 30% of days and was managed at home nine-tenths of the time. Girls reported more days with pain than did boys, and age was positively correlated with the length of the painful episodes. The pain affected school attendance and sleep. Patients were absent from school on 21% of 3186 school days, with half of the absenteeisms on days with reported pain. Of the pain-associated absenteeisms, two-thirds occurred when pain was managed at home, and one-third when patients were hospitalized. The average consecutive number of school days missed was 2.7. These findings have implications for developmentally critical activities.

Entities:  

Mesh:

Year:  1995        PMID: 7644237     DOI: 10.1016/0304-3959(94)00164-A

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  47 in total

1.  Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease.

Authors:  Alyssa M Schlenz; Jeffrey Schatz; Catherine B McClellan; Carla W Roberts
Journal:  J Pediatr Psychol       Date:  2012-03-30

2.  Is treatment adherence associated with better quality of life in children with sickle cell disease?

Authors:  Lamia P Barakat; Meredith Lutz; Kim Smith-Whitley; Kwaku Ohene-Frempong
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

3.  The Cellie Coping Kit for Sickle Cell Disease: Initial acceptability and feasibility.

Authors:  Meghan L Marsac; Olivia G Klingbeil; Aimee K Hildenbrand; Melissa A Alderfer; Nancy Kassam-Adams; Kim Smith-Whitley; Lamia P Barakat
Journal:  Clin Pract Pediatr Psychol       Date:  2014-12-01

4.  Fast track admission for children with sickle cell crises. Should morphine or pethidine be given?

Authors:  P Daggett
Journal:  BMJ       Date:  1998-03-21

5.  Feasibility and Acceptability of Internet-delivered Cognitive Behavioral Therapy for Chronic Pain in Adolescents With Sickle Cell Disease and Their Parents.

Authors:  Tonya M Palermo; Joanne Dudeney; James P Santanelli; Alexie Carletti; William T Zempsky
Journal:  J Pediatr Hematol Oncol       Date:  2018-03       Impact factor: 1.289

6.  iACT--an interactive mHealth monitoring system to enhance psychotherapy for adolescents with sickle cell disease.

Authors:  Chihwen Cheng; R Clark Brown; Lindsey L Cohen; Janani Venugopalan; Todd H Stokes; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

7.  Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study.

Authors:  Soumitri Sil; Lindsey L Cohen; Nitya Bakshi; Amanda Watt; Morgan Hathaway; Farida Abudulai; Carlton Dampier
Journal:  Clin J Pain       Date:  2020-06       Impact factor: 3.442

8.  Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.

Authors:  Jennifer Horst; Melissa Frei-Jones; Elena Deych; William Shannon; Evan D Kharasch
Journal:  Pediatr Blood Cancer       Date:  2016-08-30       Impact factor: 3.167

9.  Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.

Authors:  Robert E Molokie; Diana J Wilkie; Harriett Wittert; Marie L Suarez; Yingwei Yao; Zhongsheng Zhao; Ying He; Zaijie J Wang
Journal:  Eur J Pharmacol       Date:  2013-11-07       Impact factor: 4.432

10.  Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events.

Authors:  Amanda M Brandow; David C Brousseau; Julie A Panepinto
Journal:  Br J Haematol       Date:  2008-12-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.